CD47 and systemic lupus erythematosus: Considering that contradictory effects of CD47 blockade, presumably due to the macrophage activation, have been reported in lupus and EAE mouse models, further studies are needed to assess the therapeutic effects of anti-CD47 mAb in AAV mouse models with active disease.